hotspot
Previous article:
How one medical school became remarkably diverse
Next article: Lilly's Alzheimer's drug donanemab backed by FDA advisers
Next article: Lilly's Alzheimer's drug donanemab backed by FDA advisers
focus
hotspot
-
Activists slam private health insurers over coverage restrictions
2025-10-02 21:17 -
Teladoc has a new CEO, but challenges remain the same
2025-10-02 20:32 -
Curing rare childhood diseases will falter unless Congress steps up
2025-10-02 20:21 -
Wildfire smoke exposes gaps in outdoor worker protections
2025-10-02 20:10 -
In age of alternative facts, a scholarly course on calling out crap
2025-10-02 20:05 -
The system is set up to fail children with medical complexity
2025-10-02 19:38